103 related articles for article (PubMed ID: 12119231)
1. Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Kumaki F; Takeda K; Yu ZX; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2002 Jul; 166(2):187-91. PubMed ID: 12119231
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355
[TBL] [Abstract][Full Text] [Related]
3. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Matsui K; Takeda K; Yu ZX; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Feb; 124(2):267-75. PubMed ID: 10656737
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.
Usuki J; Horiba K; Chu SC; Moss J; Ferrans VJ
Arch Pathol Lab Med; 1998 Oct; 122(10):895-902. PubMed ID: 9786350
[TBL] [Abstract][Full Text] [Related]
5. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750
[TBL] [Abstract][Full Text] [Related]
6. High levels of exhaled nitric oxide (NO) and NO synthase III expression in lesional smooth muscle in lymphangioleiomyomatosis.
Dweik RA; Laskowski D; Ozkan M; Farver C; Erzurum SC
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):414-8. PubMed ID: 11306434
[TBL] [Abstract][Full Text] [Related]
7. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
8. Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis.
Zhe X; Schuger L
J Histochem Cytochem; 2004 Dec; 52(12):1537-42. PubMed ID: 15557209
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients.
Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K
Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043
[TBL] [Abstract][Full Text] [Related]
10. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.
Inoue Y; King TE; Barker E; Daniloff E; Newman LS
Am J Respir Crit Care Med; 2002 Sep; 166(5):765-73. PubMed ID: 12204879
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C
Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706
[TBL] [Abstract][Full Text] [Related]
15. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.
Karbowniczek M; Astrinidis A; Balsara BR; Testa JR; Lium JH; Colby TV; McCormack FX; Henske EP
Am J Respir Crit Care Med; 2003 Apr; 167(7):976-82. PubMed ID: 12411287
[TBL] [Abstract][Full Text] [Related]
16. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
Taveira-DaSilva AM; Hedin C; Stylianou MP; Travis WD; Matsui K; Ferrans VJ; Moss J
Am J Respir Crit Care Med; 2001 Sep; 164(6):1072-6. PubMed ID: 11587999
[TBL] [Abstract][Full Text] [Related]
17. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
Valencia JC; Steagall WK; Zhang Y; Fetsch P; Abati A; Tsukada K; Billings E; Hearing VJ; Yu ZX; Pacheco-Rodriguez G; Moss J
Chest; 2015 Mar; 147(3):771-777. PubMed ID: 25411763
[TBL] [Abstract][Full Text] [Related]
18. Extrapulmonary lymphangioleiomyomatosis presented as the asymptomatic retroperitoneal tumours--two cases report.
Słodkowska J; Patera J; Breborowicz J; Jarzemska A; Korzeniewska-Kosela M; Siemiatkowska K; Radzikowska E; Przybylski G; Kozłowski W
Pol J Pathol; 2006; 57(4):205-7. PubMed ID: 17285764
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
De Rosa N
Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis.
Bittmann I; Rolf B; Amann G; Löhrs U
Hum Pathol; 2003 Jan; 34(1):95-8. PubMed ID: 12605373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]